# Commission Implementing Decision (EU) 2015/1554 of 11 September 2015 laying down rules for the application of Directive 2006/88/EC as regards requirements for surveillance and diagnostic methods (notified under document C(2015) 6188) (Text with EEA relevance), Division II.2: Diagnostic methods to obtain and maintain disease-free status for either VHS or IHN or both

Extent: E+W+S+N.I.

The diagnostic method, in accordance with the approved diagnostic methods and procedures set out in point I. of Part 1 of Annex II, to achieve or to maintain disease-free status for VHS or IHN or both shall be either:
(a)virus isolation in cell cultures followed by identification using enzyme-linked immunosorbent assay (ELISA), indirect fluorescent antibody test (IFAT), virus neutralisation test or real-time reverse transcriptase polymerase chain reaction (RT-qPCR); or
(b)RT-qPCR.

---
Source: https://www.legislation.gov.uk/eudn/2015/1554/annex/I/part/1/division/II/division/II.2 (the official version)
Page: https://openlegislation.uk/eu-decision-2015-1554/annex-I/part-1/division-II/division-II.2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.